Santosh Tiwari
Hyderabad, TG 500081, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison.
Journal: Journal of comparative effectiveness research
Published: January 04, 2024
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis.
Journal: Journal of comparative effectiveness research
Published: June 02, 2023
Real-world treatment satisfaction with erenumab in migraine: analysis of the US National Health and Wellness Survey.
Journal: Current medical research and opinion
Published: March 15, 2023
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non-interventional study using claims data from the United States.
Journal: Headache
Published: January 27, 2023
Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine.
Journal: Current medical research and opinion
Published: October 03, 2022
Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence analysis from a societal perspective in Germany.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: October 11, 2021
Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain.
Journal: Journal of medical economics
Published: July 27, 2021
Fluoride-Induced Expression of Neuroinflammatory Markers and Neurophysiological Regulation in the Brain of Wistar Rat Model.
Journal: Biological trace element research
Published: June 17, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026